The role of teicoplanin in the treatment of SARS‐CoV‐2 infection: A retrospective study in critically ill COVID‐19 patients (Tei‐COVID study)

Teicoplanin has a potential antiviral activity expressed against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and was suggested as a complementary option to treat coronavirus disease 2019 (COVID‐19) patients. In this multicentric, retrospective, observational research the aim was to...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Med Virol
Prif Awduron: Ceccarelli, Giancarlo, Alessandri, Francesco, Oliva, Alessandra, Borrazzo, Cristian, Dell'Isola, Serena, Ialungo, Anna Maria, Rastrelli, Elena, Pelli, Massimiliano, Raponi, Giammarco, Turriziani, Ombretta, Ruberto, Franco, Rocco, Monica, Pugliese, Francesco, Russo, Alessandro, d'Ettorre, Gabriella, Venditti, Mario
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2021
Pynciau:
Research Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250836/
https://ncbi.nlm.nih.gov/pubmed/33675235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26925
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg